Short interest in Humana Inc (NYSE:HUM) increased during the last reporting period, rising from 3.44M to 3.94M. This put 3.67% of the company's publicly available shares short. Short interest in ...

Humana faces industry headwinds with Medicare Advantage pressures, but management maintains 2025 earnings guidance and steady operational performance. HUM stock trades at a discount to peers, ...

Humana's stock has declined 18% while the S&P 500 returned 13.5%, driven by short-term issues with Medicare Advantage. Despite short-term cost challenges, Medicare Advantage remains a long-term ...